235 related articles for article (PubMed ID: 1898652)
21. Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate.
Pang SC; Greendale GA; Cedars MI; Gambone JC; Lozano K; Eggena P; Judd HL
Fertil Steril; 1993 Jan; 59(1):76-82. PubMed ID: 8419226
[TBL] [Abstract][Full Text] [Related]
22. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
[TBL] [Abstract][Full Text] [Related]
23. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
Slater CC; Hodis HN; Mack WJ; Shoupe D; Paulson RJ; Stanczyk FZ
Menopause; 2001; 8(3):200-3. PubMed ID: 11355042
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women.
Cagnacci A; Melis GB; Soldani R; Paoletti AM; Gambacciani M; Spinetti A; Fioretti P
Maturitas; 1991 Oct; 13(4):283-96. PubMed ID: 1775082
[TBL] [Abstract][Full Text] [Related]
25. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
26. [Use of estrogens in skin patches in treatment of pre-menstrual syndrome].
Liber Z; Spiewankiewicz B; Stelmachów J
Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1018-20. PubMed ID: 1305712
[TBL] [Abstract][Full Text] [Related]
27. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
28. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Reginster JY; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet AN; Franchimont P
Calcif Tissue Int; 1993 Jul; 53(1):13-6. PubMed ID: 8394191
[TBL] [Abstract][Full Text] [Related]
29. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
[TBL] [Abstract][Full Text] [Related]
30. Sustained-release subdermal estradiol implants: a new alternative in estrogen replacement therapy.
Suhonen SP; Allonen HO; Lähteenmäki P
Am J Obstet Gynecol; 1993 Nov; 169(5):1248-54. PubMed ID: 8238193
[TBL] [Abstract][Full Text] [Related]
31. Estrogen replacement therapy by transdermal estradiol administration.
Laufer LR; DeFazio JL; Lu JK; Meldrum DR; Eggena P; Sambhi MP; Hershman JM; Judd HL
Am J Obstet Gynecol; 1983 Jul; 146(5):533-40. PubMed ID: 6407324
[TBL] [Abstract][Full Text] [Related]
32. Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
Pedersen OD; Jensen HK
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):593-8. PubMed ID: 1336917
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
34. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle.
Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Erfling W; Braverman DZ; Szczepanik-van Leeuwen P; Klein PD
J Clin Invest; 1981 Nov; 68(5):1229-42. PubMed ID: 7298849
[TBL] [Abstract][Full Text] [Related]
35. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
[TBL] [Abstract][Full Text] [Related]
36. Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol.
Matsui S; Yasui T; Kasai K; Keyama K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
J Obstet Gynaecol; 2017 Jul; 37(5):627-632. PubMed ID: 28317410
[TBL] [Abstract][Full Text] [Related]
37. Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Bellantoni MF; Harman SM; Cullins VE; Engelhardt SM; Blackman MR
J Gerontol; 1991 Nov; 46(6):M216-22. PubMed ID: 1834727
[TBL] [Abstract][Full Text] [Related]
38. [Transdermal and oral hormone substitution with estrogens: a comparison].
Schindler AE
Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
[TBL] [Abstract][Full Text] [Related]
39. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
40. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
